As of January 22, 2025, Hester Biosciences (HESTERBIO.NS) has a market cap of $0.21 billion USD. According to our data, Hester Biosciences is ranked No.7042 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.21 B |
-9.38%
|
Dec 31, 2024 | $0.24 B |
64.98%
|
Dec 29, 2023 | $0.14 B |
-18.25%
|
Dec 30, 2022 | $0.18 B |
-28.92%
|
Dec 31, 2021 | $0.25 B |
48.81%
|
Dec 31, 2020 | $0.17 B |
18.34%
|
Dec 31, 2019 | $0.14 B |
28.91%
|
Dec 31, 2018 | $0.11 B |
-38.64%
|
Dec 29, 2017 | $0.18 B |
160.92%
|
Dec 30, 2016 | $67.77 M |
29.35%
|
Dec 31, 2015 | $52.39 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Zoetis
ZTS
|
$75.18 B |
-0.001 M
|
USA
|
Elanco
ELAN
|
$5.98 B |
0.000 M
|
USA
|
Phibro Animal Health
PAHC
|
$0.88 B |
0.439 B
|
USA
|
IDEXX Laboratories
IDXX
|
$35.26 B |
-0.002 M
|
USA
|
Neogen
NEOG
|
$2.59 B |
0.000 M
|
USA
|
PetIQ
PETQ
|
$0.93 B |
0.000 M
|
USA
|
Market Cap | = | HESTERBIO.NS Stock Price | * | HESTERBIO.NS Shares Outstanding |
= | $25.14 | * | 8.51 M | |
= | $0.21 B |